Skip to main content
. 2018 Dec 7;110(1):279–288. doi: 10.1111/cas.13876

Figure 3.

Figure 3

The CCR2 antagonist restored the sensitivity of DU145‐TxR and DU145‐TxR/CxR cells to cabazitaxel. (A) DU145‐TxR and (B) DU145‐TxR/CxR cells (2 × 104 cells/mL) were exposed to 10 μg/mL CCR2 antagonist or 3 nmol/L cabazitaxel or a combination of both for 24 h and a TUNEL assay was performed. Data are shown as means ± SEM (n = 3)